264 related articles for article (PubMed ID: 24374242)
1. Insight into the structural mechanism for PKBα allosteric inhibition by molecular dynamics simulations and free energy calculations.
Chen SF; Cao Y; Han S; Chen JZ
J Mol Graph Model; 2014 Mar; 48():36-46. PubMed ID: 24374242
[TBL] [Abstract][Full Text] [Related]
2. Binding selectivity studies of PKBα using molecular dynamics simulation and free energy calculations.
Chen SF; Cao Y; Chen JJ; Chen JZ
J Mol Model; 2013 Nov; 19(11):5097-112. PubMed ID: 24085537
[TBL] [Abstract][Full Text] [Related]
3. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
[TBL] [Abstract][Full Text] [Related]
4. Microsecond molecular dynamics simulations provide insight into the ATP-competitive inhibitor-induced allosteric protection of Akt kinase phosphorylation.
Mou L; Cui T; Liu W; Zhang H; Cai Z; Lu S; Gao G
Chem Biol Drug Des; 2017 May; 89(5):723-731. PubMed ID: 27797456
[TBL] [Abstract][Full Text] [Related]
5. Theoretical study on the interaction of pyrrolopyrimidine derivatives as LIMK2 inhibitors: insight into structure-based inhibitor design.
Shen M; Zhou S; Li Y; Li D; Hou T
Mol Biosyst; 2013 Oct; 9(10):2435-46. PubMed ID: 23881296
[TBL] [Abstract][Full Text] [Related]
6. Insight into the binding modes and inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase.
Chen H; Zhang Y; Ye C; Feng TT; Han JG
J Biomol Struct Dyn; 2014; 32(8):1231-47. PubMed ID: 23815795
[TBL] [Abstract][Full Text] [Related]
7. Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition.
Calleja V; Laguerre M; Parker PJ; Larijani B
PLoS Biol; 2009 Jan; 7(1):e17. PubMed ID: 19166270
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling and molecular dynamics simulation studies on pyrrolopyrimidine-based α-helix mimetic as dual inhibitors of MDM2 and MDMX.
Lu SY; Jiang YJ; Zou JW; Wu TX
J Mol Graph Model; 2011 Sep; 30():167-78. PubMed ID: 21820342
[TBL] [Abstract][Full Text] [Related]
9. Unconventional plasticity of HIV-1 reverse transcriptase: how inhibitors could open a connection "gate" between allosteric and catalytic sites.
Bellucci L; Angeli L; Tafi A; Radi M; Botta M
J Chem Inf Model; 2013 Dec; 53(12):3117-22. PubMed ID: 24256065
[TBL] [Abstract][Full Text] [Related]
10. Insight into the Binding of DFG-out Allosteric Inhibitors to B-Raf Kinase Using Molecular Dynamics and Free Energy Calculations.
Coronel L; Granadino-Roldán JM; Pinto M; Tomas MS; Pujol MD; Rubio-Martinez J
Curr Comput Aided Drug Des; 2015; 11(2):124-36. PubMed ID: 26135342
[TBL] [Abstract][Full Text] [Related]
11. Binding and discerning interactions of PTP1B allosteric inhibitors: novel insights from molecular dynamics simulations.
Shinde RN; Sobhia ME
J Mol Graph Model; 2013 Sep; 45():98-110. PubMed ID: 24012873
[TBL] [Abstract][Full Text] [Related]
12. Understanding the relative affinity and specificity of the pleckstrin homology domain of protein kinase B for inositol phosphates.
Rosen SA; Gaffney PR; Spiess B; Gould IR
Phys Chem Chem Phys; 2012 Jan; 14(2):929-36. PubMed ID: 22121510
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulation and free energy calculation studies of kinase inhibitors binding to active and inactive conformations of VEGFR-2.
Wu X; Wan S; Wang G; Jin H; Li Z; Tian Y; Zhu Z; Zhang J
J Mol Graph Model; 2015 Mar; 56():103-12. PubMed ID: 25594497
[TBL] [Abstract][Full Text] [Related]
14. Elucidating specificity of an allosteric inhibitor WNK476 among With-No-Lysine kinase isoforms using molecular dynamic simulations.
Amarnath Jonniya N; Sk MF; Kar P
Chem Biol Drug Des; 2021 Sep; 98(3):405-420. PubMed ID: 33969941
[TBL] [Abstract][Full Text] [Related]
15. Unraveling the allosteric inhibition mechanism of PTP1B by free energy calculation based on umbrella sampling.
Cui W; Cheng YH; Geng LL; Liang DS; Hou TJ; Ji MJ
J Chem Inf Model; 2013 May; 53(5):1157-67. PubMed ID: 23621621
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Akt1 allosteric site to identify novel scaffolds through virtual screening.
Yilmaz OG; Olmez EO; Ulgen KO
Comput Biol Chem; 2014 Feb; 48():1-13. PubMed ID: 24291487
[TBL] [Abstract][Full Text] [Related]
17. Molecular simulation studies on the binding selectivity of 2-anilino-4-(thiazol-5-yl)-pyrimidines in complexes with CDK2 and CDK7.
Chohan TA; Qian HY; Pan YL; Chen JZ
Mol Biosyst; 2016 Jan; 12(1):145-61. PubMed ID: 26565382
[TBL] [Abstract][Full Text] [Related]
18. Computational studies on the binding mechanism between triazolone inhibitors and Chk1 by molecular docking and molecular dynamics.
Lv M; Ma S; Tian Y; Zhang X; Lv W; Zhai H
Mol Biosyst; 2015 Jan; 11(1):275-86. PubMed ID: 25372494
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics simulation and free energy calculation studies of the binding mechanism of allosteric inhibitors with p38α MAP kinase.
Yang Y; Shen Y; Liu H; Yao X
J Chem Inf Model; 2011 Dec; 51(12):3235-46. PubMed ID: 22097958
[TBL] [Abstract][Full Text] [Related]
20. The binding mechanism of a novel nicotinamide isostere inhibiting with TNKSs: a molecular dynamic simulation and binding free energy calculation.
Feng TT; Zhang YJ; Chen H; Fan S; Han JG
J Biomol Struct Dyn; 2016; 34(3):517-28. PubMed ID: 25933061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
